title: Wharton's Jelly stem cells: future clinical applications.
abstract: This review focuses on the therapeutic potential of stem cells harvested from the Wharton's Jelly of the human umbilical cord. Recently, investigators have found that a potent stem cell population exists within the Wharton's Jelly. In this review, the authors define a new subset of stem cells, termed perinatal stem cells, and compare them to other sources of stem cells. Furthermore, cryopreservation of Wharton's Jelly stem cells is described for potential use in future cell based therapies and/or regenerative medicine applications. Current evidence of the application of mesenchymal stem cells from various sources in both pre-clinical and clinical trials is reviewed in the context of potential indications of use for Wharton's Jelly derived mesenchymal stem cells.
authors: AuxoCell Laboratories, Inc., 245 First Street, Cambridge, MA 02142, USA.
authors: R R
authors: RR
authors: Taghizadeh
authors: K J
authors: KJ
authors: Cetrulo
authors: C L
authors: CL
authors: Cetrulo
mesh_terms: D002454:Cell Differentiation / Q000502:physiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D011247:Pregnancy; D044968:Regenerative Medicine / Q000379:methods; D033581:Stem Cell Transplantation / Q000379:methods*; D014470:Umbilical Cord / Q000166:cytology*; D059631:Wharton Jelly / Q000166:cytology*